Ziaeian B, Fonarow GC. Epidemiology and aetiology of Heart Failure. Nat Reviews Cardiol. 2016;13(6):368–78.

Article  Google Scholar 

Pearson-Stuttard J, Guzman-Castillo M, Penalvo JL, Rehm CD, Afshin A, Danaei G, et al. Modeling future Cardiovascular Disease mortality in the United States: national trends and racial and ethnic disparities. Circulation. 2016;133(10):967–78.

Article  PubMed  PubMed Central  Google Scholar 

Farré N, Vela E, Clèries M, Bustins M, Cainzos-Achirica M, Enjuanes C, et al. Medical resource use and expenditure in patients with chronic Heart Failure: a population‐based analysis of 88 195 patients. Eur J Heart Fail. 2016;18(9):1132–40.

Article  PubMed  Google Scholar 

Xu H, Granger BB, Drake CD, Peterson ED, Dupre ME. Effectiveness of telemedicine visits in reducing 30-day readmissions among patients with Heart Failure during the COVID‐19 pandemic. J Am Heart Association. 2022;11(7):e023935.

Article  Google Scholar 

Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K, et al. Acute Heart Failure. Nat Reviews Disease Primers. 2020;6(1):16.

Article  PubMed  Google Scholar 

Anderson SL, Marrs JC. A review of the role of the pharmacist in Heart Failure transition of care. Adv Therapy. 2018;35:311–23.

Article  Google Scholar 

Farah Yusuf Mohamud M, Jeele MOO, Cetinkaya O, Goitom Sereke S, Bongomin F, AM Ahmed M. Baseline characteristics, risk factors and etiology of Heart Failure among patients hospitalized at a Teaching Hospital in Somalia: cross-sectional study. Res Rep Clin Cardiol. 2022:63–71.

Goldgrab D, Balakumaran K, Kim MJ, Tabtabai SR. Updates in Heart Failure 30-day readmission prevention. Heart Fail Rev. 2019;24:177–87.

Article  CAS  PubMed  Google Scholar 

Chamberlain RS, Sond J, Mahendraraj K, Lau CS, Siracuse BL. Determining 30-day readmission risk for Heart Failure patients: the Readmission after Heart Failure scale. Int J Gen Med. 2018:127–41.

Amritphale A, Fonarow GC, Amritphale N, Omar B, Crook ED. All-cause unplanned readmissions in the United States: insights from the Nationwide Readmission Database. Intern Med J. 2023;53(2):262–70.

Article  PubMed  Google Scholar 

Butler J, Januzzi JL, Rosenstock J. Management of Heart Failure and type 2 Diabetes Mellitus: maximizing complementary drug therapy. Diabetes Obes Metabolism. 2020;22(8):1243–62.

Article  CAS  Google Scholar 

Omboni S, Volpe M. Angiotensin receptor blockers versus angiotensin converting enzyme inhibitors for the treatment of arterial Hypertension and the role of olmesartan. Adv Therapy. 2019;36(2):278–97.

Article  CAS  Google Scholar 

Croke K. The origins of Ethiopia’s primary health care expansion: the politics of state building and health system strengthening. Health Policy Plann. 2020;35(10):1318–27.

Article  Google Scholar 

Organization WH. ICD-11 for mortality and morbidity statistics (2018). 2018.

Shah M, Patil S, Patel B, Agarwal M, Davila CD, Garg L, et al. Causes and predictors of 30-day readmission in patients with acute Myocardial Infarction and cardiogenic shock. Circulation: Heart Failure. 2018;11(4):e004310.

PubMed  Google Scholar 

Bhosale KH, Nath RK, Pandit N, Agarwal P, Khairnar S, Yadav B, et al. Rate of rehospitalization in 60 days of discharge and it’s determinants in patients with Heart Failure with reduced ejection fraction in a Tertiary Care Centre in India. Int J Heart Fail. 2020;2(2):131–44.

Article  PubMed  PubMed Central  Google Scholar 

Kim LK, Yeo I, Cheung JW, Swaminathan RV, Wong SC, Charitakis K, et al. Thirty-day readmission rates, timing, causes, and costs after ST‐Segment–elevation Myocardial Infarction in the United States: a national readmission database analysis 2010–2014. J Am Heart Association. 2018;7(18):e009863.

Article  Google Scholar 

Sud M, Yu B, Wijeysundera HC, Austin PC, Ko DT, Braga J, et al. Associations between short or long length of stay and 30-day readmission and mortality in hospitalized patients with Heart Failure. JACC: Heart Failure. 2017;5(8):578–88.

PubMed  Google Scholar 

Reynolds K, Butler MG, Kimes TM, Rosales AG, Chan W, Nichols GA. Relation of acute Heart Failure hospital length of stay to subsequent readmission and all-cause mortality. Am J Cardiol. 2015;116(3):400–5.

Article  PubMed  Google Scholar 

Santhakumaran S. Statistical implications of centralised care for estimating neonatal unit mortality rates. 2016.

Wang N, Gallagher R, Sze D, Hales S, Tofler G. Predictors of frequent readmissions in patients with Heart Failure. Heart Lung and Circulation. 2019;28(2):277–83.

Article  Google Scholar 

Huynh QL, Blizzard CL, Marwick TH, Negishi K. Association of ambient particulate matter with Heart Failure incidence and all-cause readmissions in Tasmania: an observational study. BMJ open. 2018;8(5):e021798.

Article  PubMed  PubMed Central  Google Scholar 

Kaya H, Yıldırımlı MK, Kurt R, Beton O, Yilmaz MB. Mean platelet volume as a predictor of heart failure-related hospitalizations in stable Heart Failure outpatients with sinus rhythm. Acta Cardiol Sinica. 2017;33(3):292.

Google Scholar 

Fumagalli C, Maurizi N, Marchionni N, Fornasari D. β-blockers: their new life from Hypertension to cancer and migraine. Pharmacol Res. 2020;151:104587.

Article  CAS  PubMed  Google Scholar 

Pandhi P, Ter Maaten JM, Emmens JE, Struck J, Bergmann A, Cleland JG, et al. Clinical value of pre-discharge bio‐adrenomedullin as a marker of residual congestion and high risk of Heart Failure hospital readmission. Eur J Heart Fail. 2020;22(4):683–91.

Article  CAS  PubMed  Google Scholar 

Kruik-Kollöffel WJ, van der Palen J, Doggen CJ, van Maaren MC, Kruik HJ, Heintjes EM, et al. Heart Failure medication after a first hospital admission and risk of Heart Failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: a retrospective cohort study in linked databases. PLoS ONE. 2020;15(12):e0244231.

Article  PubMed  PubMed Central  Google Scholar 

Kaneko H, Suzuki S, Goto M, Arita T, Yuzawa Y, Yagi N, et al. Incidence and predictors of rehospitalization of acute Heart Failure patients. Int Heart J. 2015;56(2):219–25.

Article  PubMed  Google Scholar 

Chung J, Noh E, Gwak H. Evaluation of the predictors of readmission in Korean patients with Heart Failure. J Clin Pharm Ther. 2017;42(1):51–7.

Article  CAS  PubMed  Google Scholar 

Faselis C, Fonarow GC, Ahmed A. Reply: diuretics after Heart Failure hospitalization, not for all! J Am Coll Cardiol. 2020;76(20):2418–20.

Article  PubMed  Google Scholar 

Parajuli P, Lara-Garcia OE, Regmi MR, Skoza W, Bhattarai M, Kulkarni A, et al. Heart Failure drug Class effects on 30-Day readmission rates in patients with Heart Failure with preserved ejection fraction: a retrospective single Center Study. Medicines. 2020;7(5):30.

Article  PubMed  PubMed Central  Google Scholar 

Alshibani M, Alshehri S, Alyazidi W, Alnomani A, Almatruk Z, Almeleebia T, editors. The impact of discharged Loop Diuretic dose to Home Dose on Hospital readmissions in patients with Acute Decompensated Heart Failure: a retrospective cohort study. The heart surgery forum; 2020.

Bloomfield GS, Barasa FA, Doll JA, Velazquez EJ. Heart Failure in sub-saharan Africa. Curr Cardiol Rev. 2013;9(2):157–73.

Article  PubMed  PubMed Central  Google Scholar 

Pallangyo P, Millinga J, Bhalia S, Mkojera Z, Misidai N, Swai HJ, et al. Medication adherence and survival among hospitalized Heart Failure patients in a tertiary hospital in Tanzania: a prospective cohort study. BMC Res Notes. 2020;13(1):1–8.

Article  Google Scholar 

Getachew M. Assessment of Patients‟ readiness for Hospital Discharge and Associated factors among medical emergency patients. Black Lion Specialized Teaching Hospital Adult Emergency Department. Addis Ababa, Ethiopia Addis Abeba University Research Repositery; 2020 G.C.

Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, et al. The use of diuretics in Heart Failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(2):137–55.

Article  PubMed  Google Scholar 

Cheng RK, Levy WC, Vasbinder A, Teruya S, De Los Santos J, Leedy D, et al. Diuretic dose and NYHA functional class are Independent predictors of mortality in patients with transthyretin cardiac amyloidosis. Cardio Oncol. 2020;2(3):414–24.

Google Scholar